Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors

Explore recent improvements in the use of PARP inhibitors to treat ovarian cancer with this IME-certified program featuring an on-demand Webcast and downloadable slides.

This educational program is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

GlaxoSmithKline